Miracle Mile Advisors LLC Grows Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Miracle Mile Advisors LLC raised its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 28.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 21,475 shares of the financial services provider’s stock after acquiring an additional 4,782 shares during the period. Miracle Mile Advisors LLC’s holdings in iShares Biotechnology ETF were worth $2,839,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Choreo LLC increased its stake in shares of iShares Biotechnology ETF by 54.9% during the second quarter. Choreo LLC now owns 3,465 shares of the financial services provider’s stock worth $475,000 after acquiring an additional 1,228 shares during the period. Oppenheimer Asset Management Inc. raised its stake in shares of iShares Biotechnology ETF by 9.6% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 24,424 shares of the financial services provider’s stock worth $3,352,000 after buying an additional 2,141 shares in the last quarter. One Capital Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the 2nd quarter valued at approximately $400,000. Edgestream Partners L.P. boosted its stake in shares of iShares Biotechnology ETF by 18.6% in the second quarter. Edgestream Partners L.P. now owns 3,772 shares of the financial services provider’s stock valued at $518,000 after buying an additional 591 shares in the last quarter. Finally, Perennial Investment Advisors LLC acquired a new position in iShares Biotechnology ETF during the second quarter worth $216,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 1.0 %

Shares of IBB opened at $134.02 on Tuesday. iShares Biotechnology ETF has a 52-week low of $123.60 and a 52-week high of $150.57. The company has a 50-day simple moving average of $137.95 and a 200-day simple moving average of $141.99.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.